Eagle pharmaceuticals revenue
WebJun 9, 2024 · BARHEMSYS ® (amisulpride for injection) and BYFAVO ® (remimazolam for injection) join Eagle portfolio, with an estimated combined $3.1 billion per year 1 addressable market and projected annual...
Eagle pharmaceuticals revenue
Did you know?
WebEagle Pharmaceuticals Financials Summary financials Revenue ( Q3, 2024) $65.9M Gross profit ( Q3, 2024) $45.0M Net income ( Q3, 2024) ($7.1M) Cash ( Q3, 2024) … WebMar 13, 2024 · The specialty pharmaceutical company posted revenue of $60.7 million in the period. For the year, the company reported net income of $35.6 million, or $2.73 per share, swinging to a profit in the period. Revenue was reported as $316.6 million. Eagle Pharmaceuticals expects full-year earnings in the range of $4.20 to $4.53 per share. …
WebEagle Pharmaceuticals, Inc revenue for the last year amounted to 316.61M USD, the most of which — 316.61M USD — came from its highest performing source at the moment, Injectable Drugs, the year earlier bringing 171.55M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Eagle ... WebDec 31, 2024 · Find out how Eagle Pharmaceuticals, Inc. (EGRX) is performing against its competitors. Compare financial ratios of 10,000 largest U.S. public companies with industry averages. ... 2834 - Pharmaceutical Preparations: Revenue in 2024: $171,546 thousand (ranked #190 out of 638 companies in the industry) Assets as of 12/31/2024 : $253,732 ...
WebMay 10, 2024 · Eagle Pharmaceuticals, which belongs to the Zacks Medical - Products industry, posted revenues of $41.25 million for the quarter ended March 2024, missing … WebMar 7, 2024 · Total revenue for the 12 months ended December 31, 2024 was $171.5 million, compared to $187.8 million in 2024. 2024 included a $5.0 million milestone payment from SymBio Pharmaceuticals Limited ...
WebMar 7, 2024 · Eagle Pharmaceuticals , which belongs to the Zacks Medical - Products industry, posted revenues of $42.32 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by 10.57%.
WebMar 13, 2024 · Eagle Pharmaceuticals (EGRX) Beats Q4 Earnings and Revenue Estimates Zacks Mar. 13, 2024, 08:05 AM Eagle Pharmaceuticals (EGRX) came out with quarterly earnings of $1.10 per share,... kinfolksoft.comWebMar 13, 2024 · Eagle Pharmaceuticals press release ( NASDAQ: EGRX ): Q4 Non-GAAP EPS of $1.11 beats by $0.28. Revenue of $60.7M (+43.4% Y/Y) misses by $3.56M. Q4 … kin food hallsWebApr 14, 2024 · Position: HEALTH INFORMATION TECHNOLOGY - ENTRY LEVEL /RECENT GRAD Location: Ashburn Leading edge Revenue Cycle Management … kinfolks restaurant daytona beachWebRevenue in 2024 (TTM): $0.31 B. According to Eagle Pharmaceuticals 's latest financial reports the company's current revenue (TTM) is $0.31 B . In 2024 the company made a … kinfolks manitou springs coWebMar 23, 2024 · Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results · Q4 2024 net income was $0.63 per basic and $0.62 per diluted share and adjusted non-GAAP net income was $1.11 per basic and $1.10 per diluted share 1 · Total revenue for Q4 2024 was $60.7 million, compared to $42.3 million in Q4 2024 kinfon pharmachem company ltdWebMay 9, 2024 · Q1 2024 total revenue was $115.9 million, up from $41.2 million in Q1 2024. Achieved sales of $34.3 million of vasopressin, with prior four weeks average market … kin for shortWebApr 13, 2024 · Pharmacy Relationship Manager. Job in Ashburn - VA Virginia - USA , 22011. Listing for: America's Pharmacy Group, LLC. Full Time position. Listed on 2024 … kinfon company limited